Literature DB >> 26618528

Systemic listeriosis following vaccination with the attenuated Listeria monocytogenes therapeutic vaccine, ADXS11-001.

Joseph J Sacco1,2, Mererid Evans3,4, Kevin J Harrington5, Stephen Man4, Ned Powell4, Richard J Shaw1,6, Terry M Jones1,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26618528      PMCID： PMC4962931          DOI： 10.1080/21645515.2015.1121338

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  3 in total

Review 1.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

Review 2.  ADXS-HPV: a therapeutic Listeria vaccination targeting cervical cancers expressing the HPV E7 antigen.

Authors:  Lori Cory; Christina Chu
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 3.  Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.

Authors:  Anu Wallecha; Kyla Driscoll Carroll; Paulo Cesar Maciag; Sandra Rivera; Vafa Shahabi; Yvonne Paterson
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086
  3 in total
  16 in total

1.  Listeria monocytogenes mutants defective in gallbladder replication represent safety-enhanced vaccine delivery platforms.

Authors:  Georgina C Dowd; Mohammed Bahey-El-Din; Pat G Casey; Susan A Joyce; Colin Hill; Cormac G M Gahan
Journal:  Hum Vaccin Immunother       Date:  2016-02-23       Impact factor: 3.452

2.  Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma.

Authors:  Hector Terán-Navarro; Ricardo Calderon-Gonzalez; David Salcines-Cuevas; Isabel García; Marco Marradi; Javier Freire; Erwan Salmon; Mar Portillo-Gonzalez; Elisabet Frande-Cabanes; Almudena García-Castaño; Virginia Martinez-Callejo; Javier Gomez-Roman; Raquel Tobes; Fernando Rivera; Sonsoles Yañez-Diaz; Carmen Álvarez-Domínguez
Journal:  Oncoimmunology       Date:  2018-11-10       Impact factor: 8.110

Review 3.  hrHPV E5 oncoprotein: immune evasion and related immunotherapies.

Authors:  Antonio Carlos de Freitas; Talita Helena Araújo de Oliveira; Marconi Rego Barros; Aldo Venuti
Journal:  J Exp Clin Cancer Res       Date:  2017-05-25

Review 4.  Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapy.

Authors:  Sigrun Smola; Connie Trimble; Peter L Stern
Journal:  Ther Adv Vaccines       Date:  2017-07-05

Review 5.  Tumor Immunity and Immunotherapy for HPV-Related Cancers.

Authors:  Achraf A Shamseddine; Bharat Burman; Nancy Y Lee; Dmitriy Zamarin; Nadeem Riaz
Journal:  Cancer Discov       Date:  2021-05-14       Impact factor: 39.397

6.  Enhanced therapeutic efficacy of Listeria-based cancer vaccine with codon-optimized HPV16 E7.

Authors:  Feifei Duan; Jiaqi Chen; Hao Yao; Yuting Wang; Yanyan Jia; Zhiting Ling; Youwei Feng; Zhiming Pan; Yuelan Yin; Xin'An Jiao
Journal:  Hum Vaccin Immunother       Date:  2021-01-15       Impact factor: 3.452

7.  Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.

Authors:  Petr O Ilyinskii; Grigoriy I Kovalev; Conlin P O'Neil; Christopher J Roy; Alicia M Michaud; Natalia M Drefs; Mikhail A Pechenkin; Fen-Ni Fu; Lloyd P M Johnston; Dmitry A Ovchinnikov; Takashi Kei Kishimoto
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

8.  Checkpoint blockade inhibitors enhances the effectiveness of a Listeria monocytogenes-based melanoma vaccine.

Authors:  Ryan P Gilley; Peter H Dube
Journal:  Oncotarget       Date:  2020-02-18

9.  ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer.

Authors:  Tatiana Galicia-Carmona; Eder Arango-Bravo; Juan A Serrano-Olvera; Celia Flores-de La Torre; Ivan Cruz-Esquivel; Ricardo Villalobos-Valencia; Andrés Morán-Mendoza; Denisse Castro-Eguiluz; Lucely Cetina-Pérez
Journal:  Hum Vaccin Immunother       Date:  2021-04-01       Impact factor: 3.452

Review 10.  Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress.

Authors:  John C Flickinger; Ulrich Rodeck; Adam E Snook
Journal:  Vaccines (Basel)       Date:  2018-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.